Direct Medical Costs of Spinal Muscular Atrophy in the Catalonia Region: A Population-Based Analysis.

Clinical Drug Investigation
Josep Darbà

Abstract

Spinal muscular atrophy (SMA) is a rare disorder, estimated to affect 1 per 10,000 live births. Patients affected with SMA often require intensive, chronic healthcare, which represents great social and economic costs. This study aimed to evaluate the direct medical costs of SMA, from the National Health System perspective in Catalonia, and provide regional data for the development of optimal disease management protocols and resource allocation decisions at the regional level. A retrospective, population-based study was designed based on admission records from primary care centres, hospitals and specialised care settings (inpatient and outpatient care), emergency services and extended care facilities obtained from a regional governmental claims database. A total of 396 patients met the inclusion criteria. Annual direct medical costs summed €58,606 per patient, taking into account the use of healthcare resources at all levels of care and excluding the cost of prescription medication. Specialised care represented 81% of the expenses that were mostly associated with respiratory manifestations of SMA. In the year 2016, 71.26% of patients with SMA had four or more systems affected by a chronic condition, versus 23.50% in the general ...Continue Reading

References

Dec 1, 1989·The Journal of Pediatrics·I S GilgoffT G Keens
May 26, 2004·Public Health Reports·Gerard Anderson, Jane Horvath
Jul 17, 2012·JAMA : the Journal of the American Medical Association·Mary E TinettiCynthia M Boyd
Feb 21, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Rupert A PayneStewart W Mercer
Aug 26, 2014·Assay and Drug Development Technologies·Jonathan J CherryJill Jarecki
Oct 31, 2015·Neurologic Clinics·Stephen J Kolb, John T Kissel
May 6, 2016·Orphanet Journal of Rare Diseases·Constanze KlugKlaus H Nagels
Jul 28, 2016·Risk Management and Healthcare Policy·Steven M McPhail
Aug 9, 2016·Atencion primaria·David MonterdeUNKNOWN grupo colaborativo GMA
Oct 26, 2016·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·John BusbyWilliam Hollingworth
Apr 11, 2017·Neuromuscular Disorders : NMD·Richard S FinkelUNKNOWN ENMC SMA Workshop Study Group
Jul 6, 2017·Orphanet Journal of Rare Diseases·Ingrid E C VerhaartHanns Lochmüller
Aug 20, 2017·Orphanet Journal of Rare Diseases·Julio López-BastidaJuan Oliva-Moreno
Sep 29, 2017·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Davide L VetranoLaura Fratiglioni
Feb 17, 2016·Journal of Comorbidity·Rokas NavickasMartin Seychell
Jul 17, 2018·The Annals of Pharmacotherapy·Melanie K ClabornBrooke L Gildon

❮ Previous
Next ❯

Citations

Jan 25, 2021·Orphanet Journal of Rare Diseases·Tamara DangouloffMickaël Hiligsmann
Feb 13, 2021·Applied Health Economics and Health Policy·Erik LandfeldtThomas Sejersen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.